Skip to main content
. 2018 Oct 16;2018:6369814. doi: 10.1155/2018/6369814

Table 1.

Baseline characteristics of all patients and diagnostic subgroups.

MPA GPA All
N=47 N=38 N=85 P
Males 27 (57.4) 26 (68.4) 53 (62.4) 0.30
Age (years) 62 (28-80) 52 (22-77) 58 (22-80) 0.004
Hypertonia 14 (29.8) 8 (21.1) 22 (25.9) 0.36
CVD 8 (17.0) 3 (7.9) 11 (12.9) 0.21
Creatinine (μmol/l) 250 (63-2332) 164 (56-1600) 208 (56-2332) 0.02
GFR (ml/min/1.73 m2) 17 (1-91) 35 (3-120) 24 (1-120) 0.01
ANCA PR3-ANCA 6 (12.8) 34 (89.5) 40 (47.1) <0.001
MPO-ANCA 41 (87.2) 4 (10.5) 45 (52.9)
BVAS 15 (11-26) 19 (5-39) 17 (5-39) <0.001
Proteinuria (g/day) <0.5 7 (14.9) 6 (15.8) 13 (15.3) 0.31
0.5-3.0 26 (55.3) 26 (68.4) 52 (61.2)
>3.0 14 (29.8) 6 (15.8) 20 (23.5)
Organ involvement Renal 47 (100) 38 (100) 85 (100)
 General symptoms∗∗∗ 33 (70.2) 34 (89.5) 67 (78.8) 0.03
 Lung 13 (27.7) 18 (47.4) 31 (36.5) 0.06
 ENT 2 (4.3) 23 (60.5) 25 (29.4) <0.001
 Skin 6 (12.8) 9 (23.7) 15 (17.6) 0.19
 Eyes/mucous membranes 3 (6.4) 11 (28.9) 14 (16.5) 0.01
 Nervous system 3 (6.4) 5 (13.2) 8 (9.4) 0.49∗∗
 Abdominal 5 (10.6) 1 (2.6) 6 (7.1) 0.22∗∗
 Cardiac 2 (4.3) 0 (0.0) 2 (2.4) 0.50∗∗

Data are presented as the median (range) for continuous nonnormal variables and as the number (%) for categorical variables.

GPA, granulomatosis with polyangiitis; MPA, microscopic polyangiitis (including two patients with renal limited vasculitis); CVD, cardiovascular disease; GFR, glomerular filtration rate; ANCA, anti-neutrophil cytoplasmic antibody; PR3, proteinase 3; MPO, myeloperoxidase; BVAS, Birmingham vasculitis activity score; ENT, ear, nose, and throat.

P values indicate the comparison between GPA and MPA. Mann-Whitney U test was used for nonnormal continuous variables; Chi-squared test and Fisher's exact test (∗∗) were used for categorical variables.

∗∗∗ General symptoms: fever, weight loss, arthralgia, myalgia.